Glutathione in cancer progression and chemoresistance: an update in: Redox Experimental Medicine Volume 2023 Issue 1 (2023) Targeting DDX3X suppresses progression of KRAS driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis Cell Death & Disease An anticancer agent loaded PLGA nanomedicine with glutathione response and targeted delivery for the treatment of lung cancer Journal of Materials Chemistry B (RSC Publishing) Glutathione metabolism in cancer progression and treatment resistance Journal of Cell Biology Rockefeller University Press
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
glutathione lung cancer Glutathione production profile and NRF2 expression in lung cancer cells...